Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.
Mantovani G, Maccio A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G. Mantovani G, et al. Among authors: astara g. Int J Oncol. 2000 Jun;16(6):1227-33. doi: 10.3892/ijo.16.6.1227. Int J Oncol. 2000. PMID: 10812000 Clinical Trial.
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
Mantovani G, Proto E, Massa E, Mulas C, Madeddu C, Mura L, Mudu MC, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Tore G, Mura M, Amichetti M, Maccio A. Mantovani G, et al. Among authors: astara g. Int J Oncol. 2002 Feb;20(2):419-27. Int J Oncol. 2002. PMID: 11788911 Clinical Trial.
Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.
Mantovani G, Macciò A, Massa E, Mulas C, Mudu MC, Massidda S, Massa D, Murgia V, Ferreli L, Succu G, Astara G, Proto E, Tore G, Mura M, Maxia G. Mantovani G, et al. Among authors: astara g. Oncol Rep. 1999 Nov-Dec;6(6):1425-30. doi: 10.3892/or.6.6.1425. Oncol Rep. 1999. PMID: 10523724 Clinical Trial.
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.
Massa E, Astara G, Madeddu C, Dessì M, Loi C, Lepori S, Mantovani G. Massa E, et al. Among authors: astara g. Crit Rev Oncol Hematol. 2009 Apr;70(1):83-91. doi: 10.1016/j.critrevonc.2008.07.002. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2009. PMID: 18723369 Clinical Trial.
Evaluation by multidimensional instruments of health-related quality of life of elderly cancer patients undergoing three different "psychosocial" treatment approaches. A randomized clinical trial.
Mantovani G, Astara G, Lampis B, Bianchi A, Curreli L, Orrù W, Carta MG, Carpiniello B, Contu P, Rudas N. Mantovani G, et al. Among authors: astara g. Support Care Cancer. 1996 Mar;4(2):129-40. doi: 10.1007/BF01845762. Support Care Cancer. 1996. PMID: 8673350 Clinical Trial.
Six-week induction chemotherapy followed by concomitant chemoradiation therapy in stage IV head and neck cancer: a phase II study with organ-sparing purposes.
Mantovani G, Massa E, Astara G, Murgia V, Gramignano G, Ferreli L, Camboni P, Lusso MR, Mocci M, Madeddu C, Mura L, Mudu MC, Proto E, Tore G, Mura M, Macciò A, Ferreli A, Amichetti M. Mantovani G, et al. Among authors: astara g. Oncol Rep. 2003 May-Jun;10(3):759-66. Oncol Rep. 2003. PMID: 12684655 Clinical Trial.
46 results